The four astronauts chosen for NASA's Artemis II mission have touched down at Kennedy Space Center in Florida, marking the beginning of final launch preparations for the first crewed lunar journey in over 50 years. NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, along with Canadian Space Agency astronaut Jeremy Hansen, flew in aboard Northrop T-38 jets from Houston, Texas, ahead of a targeted launch date of April 1.
The crew will lift off atop NASA's Space Launch System rocket and travel inside a Lockheed Martin-built Orion spacecraft designed specifically for deep space human exploration. The approximately 10-day mission will take the astronauts on a high-speed loop around the Moon — farther from Earth than any humans have ever traveled — before returning home.
Mission commander Wiseman expressed the team's excitement upon arrival, saying the world has been waiting a long time for this moment and that the crew is fully ready. Artemis II serves as the first crewed mission under NASA's broader Artemis program, which aims to establish a long-term human presence on the Moon as a stepping stone toward future Mars exploration.
The mission carries significant historical milestones. Glover will become the first Black astronaut to journey to lunar vicinity, Koch will be the first woman, and Hansen will be the first non-American astronaut to travel beyond low Earth orbit. The flight will validate critical Orion systems including life support, navigation, communications, and heat shield performance.
All four crew members have undergone more than two years of intensive mission training. Wiseman, Glover, and Koch each bring prior spaceflight experience, while Hansen, a Canadian astronaut since 2009, will be making his first trip to space. NASA continues developing subsequent Artemis missions to advance human deep space exploration.


Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
DogeOS Launches Testnet to Bring DeFi Apps to Dogecoin
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
DeepSeek, Huawei Partner on Ascend AI Chip Programming Tools
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
CSL Partners With AWS to Bring AI Into Drug Research
TSMC Accelerates 2nm Expansion as AI Chip Demand Surges
China vs. NASA: The New Moon Race and What's at Stake by 2030
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Tencent Signs $7 Billion Oracle AI Chip Lease Deal
OpenAI Seeks $30 Billion at $1.4 Trillion Valuation
Anthropic Targets $2 Trillion Valuation in Planned IPO
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Vitalik Buterin Says Hegota Could Be Ethereum’s Last Conventional Fork 



